Healthcare provider profile · identity verified

James David Byrum, MD

Internal Medicine · BENTONVILLE, AR · NPI 1396703252

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	165
Levothyroxine Sodium	Levothyroxine Sodium	378	96
Amlodipine Besylate	Amlodipine Besylate	351	102
Lisinopril	Lisinopril	253	69
Losartan Potassium	Losartan Potassium	219	61
Rosuvastatin Calcium	Rosuvastatin Calcium	201	59
Tramadol Hcl	Tramadol Hcl	192	32
Gabapentin	Gabapentin	178	56
Trazodone Hcl	Trazodone Hcl	176	46
Metoprolol Succinate	Metoprolol Succinate	175	47
Omeprazole	Omeprazole	161	50
Metformin Hcl	Metformin Hcl	149	41
Hydrochlorothiazide	Hydrochlorothiazide	130	39
Zolpidem Tartrate	Zolpidem Tartrate	121	20
Tamsulosin Hcl	Tamsulosin Hcl	120	39
Escitalopram Oxalate	Escitalopram Oxalate	119	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	21
Carvedilol	Carvedilol	112	31
Fluticasone Propionate	Fluticasone Propionate	105	34
Eliquis	Apixaban	102	19
Buspirone Hcl	Buspirone Hcl	99	23
Pantoprazole Sodium	Pantoprazole Sodium	98	29
Mounjaro	Tirzepatide	94	13
Sertraline Hcl	Sertraline Hcl	83	27
Famotidine	Famotidine	78	22
Tizanidine Hcl	Tizanidine Hcl	72	23
Bupropion Xl	Bupropion Hcl	70	21
Pravastatin Sodium	Pravastatin Sodium	70	23
Clonazepam	Clonazepam	68	14
Alprazolam	Alprazolam	67	13
Clopidogrel	Clopidogrel Bisulfate	67	19
Metformin Hcl Er	Metformin Hcl	65	24
Jardiance	Empagliflozin	64	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Metoprolol Tartrate	Metoprolol Tartrate	58	17
Prednisone	Prednisone	56	36
Potassium Chloride	Potassium Chloride	54	22
Citalopram Hbr	Citalopram Hydrobromide	52	14
Ozempic	Semaglutide	52	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	17
Furosemide	Furosemide	51	16
Simvastatin	Simvastatin	50	15
Spironolactone	Spironolactone	47	13
Fluoxetine Hcl	Fluoxetine Hcl	45	12
Albuterol Sulfate Hfa	Albuterol Sulfate	43	21
Cephalexin	Cephalexin	42	25
Meloxicam	Meloxicam	42	19
Alendronate Sodium	Alendronate Sodium	41	15
Atenolol	Atenolol	40	suppressed
Irbesartan	Irbesartan	40	suppressed
Xarelto	Rivaroxaban	40	11
Azithromycin	Azithromycin	39	29
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Levetiracetam	Levetiracetam	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Ondansetron Odt	Ondansetron	35	17
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Estradiol	Estradiol	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Repatha Sureclick	Evolocumab	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Finasteride	Finasteride	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Pregabalin	Pregabalin	25	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	25	suppressed
Mupirocin	Mupirocin	24	13
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Nystatin	Nystatin	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Bydureon Bcise	Exenatide Microspheres	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Caplyta	Lumateperone Tosylate	12	suppressed
Dayvigo	Lemborexant	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Forteo	Teriparatide	12	suppressed
Mycapssa	Octreotide Acetate	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Austedo	Deutetrabenazine	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error